Nūhou
-
Hoʻomaka ʻia ka GLP-1 Boom: ʻO ka hoʻomaka wale ʻana o ke kaumaha
I kēia mau makahiki i hala iho nei, ua hoʻonui wikiwiki ʻia nā agonists receptor GLP-1 mai ka mālama ʻana i ka maʻi diabetes a hiki i nā mea hana hoʻokele paona, lilo i hoʻokahi o nā ʻāpana e nānā pono ʻia i ka lāʻau lapaʻau honua.Heluhelu hou aku -
Pehea e hoʻololi ai ʻo Retatrutide i ke kaumaha
I kēia ao, ua lilo ka momona i mea maʻi maʻi e pili ana i ke olakino honua ma kahi ākea. ʻAʻole ia he mea wale nō o ka hiʻohiʻona - he mea hoʻoweliweli koʻikoʻi i ka hana cardiovascular, ...Heluhelu hou aku -
ʻO ka haki ʻana i ka Bottleneck i ka Obesity a me ka mālama maʻi diabetes: ʻO ka mana kupaianaha o Tirzepatide.
ʻO Tirzepatide kahi moʻolelo ʻelua GIP/GLP-1 receptor agonist i hōʻike i ka ʻōlelo hoʻohiki nui i ka mālama ʻana i nā maʻi metabolic. Ma ka hoʻohālikelike ʻana i nā hana o ʻelua mau hormone incretin kūlohelohe, hoʻonui ia i ...Heluhelu hou aku -
Hoemi i ka pilikia o ka na'au e 38%! Ke hoʻololi hou nei ʻo Tirzepatide i ka ʻāina o ka mālama ʻana i ka maʻi cardiovascular
ʻO Tirzepatide, kahi moʻolelo agonist pālua ʻelua (GLP-1/GIP), ua loaʻa ka manaʻo nui i nā makahiki i hala iho nei no kāna kuleana i ka mālama ʻana i ka maʻi diabetes. Eia naʻe, ʻo kona mana ...Heluhelu hou aku -
Oral Semaglutide: He Needle-Free Breakthrough in Diabetes and Weight Management
I ka wā ma mua, ua loaʻa mua ka semaglutide ma ke ʻano injectable, ka mea i pale i kekahi mau maʻi i maʻa i nā nila a makaʻu paha i ka ʻeha. I kēia manawa, ua loli ka hoʻolauna ʻana o nā papa waha ...Heluhelu hou aku -
Ke hoʻololi nei ʻo Retatrutide i ke ʻano o ka mālama ʻana i ka momona
I loko o ka nohona o kēia mau lā, ua lilo ka momona i mea paʻakikī olakino honua, a ʻo ka puka ʻana mai o Retatrutide hāʻawi i ka manaʻolana hou no nā poʻe maʻi e hakakā nei me ke kaumaha. ʻO Retatrutide kahi mea hoʻokipa triple ...Heluhelu hou aku -
Mai ke koko koko a hiki i ke kaumaha o ke kino: ka wehe ʻana i ke ʻano o ka hana hou ʻana o Tirzepatide i ka ʻāina lapaʻau no nā maʻi he nui.
I ka wā o ka holomua o ka lāʻau lapaʻau, lawe mai ʻo Tirzepatide i ka manaʻolana hou i nā poʻe maʻi me nā maʻi maʻi like ʻole ma o kāna ʻano hana ʻokoʻa o ka hana. ʻO kēia ʻano hoʻomaʻamaʻa hoʻomaʻamaʻa brea ...Heluhelu hou aku -
Nā Pōmaikaʻi Ola o nā Laʻau GLP-1
I nā makahiki i hala iho nei, ua puka mai ka GLP-1 receptor agonists (GLP-1 RAs) ma ke ʻano he kī nui i ka mālama ʻana i ka maʻi maʻi a me ka momona, e lilo ana i mea nui o ka hoʻokele maʻi metabolic. ʻO kēia mau lāʻau lapaʻau ...Heluhelu hou aku -
ʻO Semaglutide VS Tirzepatide
ʻO Semaglutide a me Tirzepatide nā lāʻau lapaʻau GLP-1 hou i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2 a me ka momona. Ua hōʻike ʻo Semaglutide i nā hopena maikaʻi aʻe i ka hōʻemi ʻana i nā pae HbA1c a me ka pro ...Heluhelu hou aku -
He aha ka Orforgliron?
ʻO Orforglipron kahi maʻi maʻi type 2 hou a me ka lāʻau lapaʻau hoʻohaʻahaʻa kaumaha ma lalo o ka hoʻomohala ʻana a ke manaʻo ʻia nei e lilo i mea ʻokoʻa waha i nā lāʻau injectable. Aia ia i ka glucagon-like peptide-1 ...Heluhelu hou aku -
He aha nā ʻokoʻa ma waena o ka mea maka o semaglutide me 99% maʻemaʻe a me 98% maʻemaʻe?
He mea koʻikoʻi ka maʻemaʻe o Semaglutide i kona pono a me ka palekana. ʻO ka ʻokoʻa nui ma waena o Semaglutide API me 99% maʻemaʻe a me 98% maʻemaʻe e waiho nei i ka nui o ka mea hana i kēia manawa a ...Heluhelu hou aku -
ʻO Tirzepatide: He Hōkū Piʻi e hoʻomālamalama ana i ka manaʻolana hou i ka mālama maʻi diabetes
Ma ka huakaʻi o ka mālama ʻana i ka maʻi diabetes, ʻālohilohi ʻo Tirzepatide e like me ka hōkū e piʻi aʻe ana, e hoʻomālamalama ana me ka nani ʻokoʻa. Hoʻopili ia i ka ʻāina ākea a paʻakikī o ka maʻi diabetes type 2, e hāʻawi ana i nā mea maʻi i kahi b ...Heluhelu hou aku